Search results
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
Wichita Eagle via Yahoo News· 8 hours agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it...
Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision
BioPharma Dive via Yahoo Finance· 5 days agoThe failure of another trial adds to uncertainty around the benefits of the gene-based treatments,...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 5 days agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remains trapped below a...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 5 days agoHowever, this is likely a good bet from management to boost the company's growth prior to interest rate cuts (which would push the valuation of Seagen...
Is It Too Late to Buy Pfizer Stock?
The Motley Fool via AOL· 4 days agoAre Pfizer's (NYSE: PFE) best days behind it? If the stock's critics are to be believed, the answer is an emphatic "yes, obviously," with issues like its...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 5 days agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
Incubators, investment: How the Life Science Hub plans to bring biotech business to RI
Gannett via AOL· 17 hours agoBut it is not 2020 anymore. Could Rhode Island...last year and has led the Hub through its initial...
Column: Justice Clarence Thomas casts cloud over lawsuits challenging diversity programs
Reuters· 5 hours agoU.S. Supreme Court Justice Clarence Thomas has just adopted a legal theory that would eliminate a...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 7 days agoPfizer expects its drug launches through the first half of this year to generate $20 billion in...
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
InvestorPlace via Yahoo Finance· 7 days agoOn Friday, the U.S. Federal Drug Administration (FDA) okayed the launch of updated vaccines as part...